Malaysia’s own
cancer vaccine
is almost ready
for its first human trial.
A decade of Malaysian science
got it this far. Your giving carries it
the rest of the way.
2012Discovery
2014Proof it works
2017Proven safe
2018DNA vaccine
NOWClinic-ready
FIRST GOALFirst human trial
Most patients still
run out of options.
Only about 13% of cancer patients
respond to immunotherapy alone,
and checkpoint inhibitors help roughly 1 in 5.
For everyone else, there is still no durable answer.


A vaccine that teaches
the body to fight back.
Our scientists identified two targets, MAGED4B and FJX1, through research involving Malaysian patients and samples. Those discoveries became the foundation of the vaccine.
In laboratory studies, adding it to existing immunotherapy raised tumour control from about 60% to as high as 97%.
Pre-clinical results. Not yet tested in humans.
“We are not asking Malaysians to believe in a miracle. We are asking them to believe in rigorous Malaysian science.”
Professor Dr Cheong Sok Ching ·
Chief Scientific Officer, Cancer Research Malaysia
Malaysian research
vaccine is patented
goes straight to research
Give any amount,
every month.
No minimum, no tiers. Research runs on years, not moments,
so a monthly gift is the most useful thing you can give.
Pick Your
Thank You Gift
Monthly giving keeps the research funded
all year round.
Pick a tier below to begin,
while stocks last.
RM 301x Umbrella
RM 501x Lapel Pin + 1x Cap
RM 1001x Tumbler + 1x Cap + 1x Lapel Pin*Gifts apply to monthly recurring donations only,
while stocks last. Lapel pin designs vary and
are subject to availability.

